CRDL · Cardiol Therapeutics Inc.
$1.89
-0.08 (-3.83%)
At close · Aug 20
Market Cap
$219.04M
Shares
116.82M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.89
Open$1.96
Day$1.83–2.00
52W close$0.93–1.96
Avg vol 30d1.2M
Short int2.3M · 1.9% float · 2.3d
Short vol35%
DataJan 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+64%
above
Price vs 50-day avg
+52%
above
RSI (14)
79
overbought
MACD trend
Positive
52-week position
93%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+53%
trailing
6-month return
+85%
trailing
YTD return
+98%
this year
Relative strength
+74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +12 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.93% of float · ▲ +1.9% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
53 holders — near 3-yr high, broad support
Squeeze score
72
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
58%
annualized · 1-yr
Max drawdown
−39%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+64%
Bullish
Price vs 50-day avg
+52%
Bullish
RSI (14)
79
Bearish
MACD trend
Positive
Bullish
52-week position
93%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Accumulating
+13% holders QoQ · +12 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.93% of float · ▲ +1.9% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
53 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $2 · 93%
Range high $2
vs 200-day avg +64%
vs 50-day avg +52%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRDL
this stock
Cardiol Therapeutics Inc.
|
$219.04M | +97.6% | — | — | 1.9% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$64.91B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$57.85B | +16.3% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$50.24B | +1.7% | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.41B | -2.4% | — | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRDL | +10.2% | +53.3% | +84.8% | +48.4% | +97.6% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +12.2% | +49.9% | +73.6% | +46.4% | +85.8% |
Key facts
CIK
1702123
CUSIP
14161Y200
13F (30d)
50 filings
49 filers
Visit website
Investor relations